Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PERRIGO COMPANY et al v. ABBVIE, INC. et al
Case Number:
2:20-cv-02132
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 22, 2020
AbbVie Gets AndroGel Monopoly Case Moved To NJ
AbbVie has persuaded a Pennsylvania federal judge to move an antitrust suit brought by Perrigo that alleges monopoly control over a blockbuster testosterone treatment to New Jersey district court.
-
September 02, 2020
Perrigo Fights AbbVie's Bid To Send Pa. Antitrust Suit To NJ
Perrigo Co. on Wednesday slammed AbbVie Inc.'s bid to send a Pennsylvania antitrust suit over a testosterone treatment to New Jersey, arguing that the Keystone State court already presided over the same claims brought by regulatory authorities.
-
May 04, 2020
Perrigo Follows FTC's Wake With AbbVie Testosterone Suit
Perrigo on Monday joined a string of litigants alleging that AbbVie engaged in "sham" patent infringement litigation to delay generic competition for its AndroGel testosterone treatment.